Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa
Double Blind, Randomised, Vehicle Controlled, Phase III, Efficacy and Safety Study With 24-month Open-label Follow up of Oleogel-S10 in Patients With Inherited Epidermolysis Bullosa Double Blind, Randomised, Vehicle Controlled, Phase III, Efficacy and Safety Study With 24-month Ope ...
Epidermolysis Bullosa
Drug: Oleogel-S10;Drug: Control gel
Amryt Research Limited
NULL
Completed
21 Days
N/A
All
223
Phase 3
United States;Argentina;Australia;Austria;Brazil;Chile;Colombia;Czechia;Denmark;France;Georgia;Germany;Greece;Hong Kong;Hungary;Ireland;Israel;Italy;Romania;Russian Federation;Serbia;Singapore;Spain;Switzerland;Ukraine;United Kingdom;Belgium;Croatia United States;Argentina;Australia;Austria;Brazil;Chile;Colombia;Czechia;Denmark;France;Georgia;Germa ...